drugset

drugset / Trial / NCT00520754

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

NCT00520754 ↗

Phase 2 Completed 15 enrolled UCB Pharma

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Timeline

Start: 2001-12
Primary completion: 2003-03
Completion: 2003-03

Publications

Results Cranswick N, Turzikova J, Fuchs M, Hulhoven R. Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile. Int J Clin Pharmacol Ther. 2005 Apr;43(4):172-7. doi: 10.5414/cpp43172.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levocetirizine	Unknown	0.125 mg/kg	Oral

Indications

No indication recorded.